The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
β-Blocker Therapy and Symptoms of Depression, Fatigue, and Sexual Dysfunction
Abstract
CONTEXT: beta-Blocker therapy remains substantially underused in cardiac patients despite its proven mortality benefits. Reluctance to prescribe these agents may derive from concerns about their association with symptoms of depression, fatigue, and sexual dysfunction. OBJECTIVE: To determine the association of beta-blockers with depressive symptoms, fatigue, and sexual dysfunction by performing a quantitative review of randomized trials that tested beta-blockers in myocardial infarction, heart failure, and hypertension. DATA SOURCES: Randomized trials of beta-blockers used in the treatment of myocardial infarction, heart failure, or hypertension were identified by searching the MEDLINE database for English-language articles (1966-2001). In addition, we searched the reference lists of previously published trials and reviews of beta-blockers for additional studies. STUDY SELECTION: Criteria for inclusion of trials in the review were: random allocation of study treatments, placebo control, noncrossover design, enrollment of at least 100 patients, and a minimum of 6 months of follow-up. The initial search produced 475 articles, 42 of which met these criteria. Fifteen of these trials reported on depressive symptoms, fatigue, or sexual dysfunction and were selected for inclusion. DATA EXTRACTION: For each trial, 1 author abstracted the frequency of adverse events in the beta-blocker and placebo groups and the numbers of patients randomized to the treatment groups. Two other authors verified the counts of events, and all authors adjudicated any discrepancies. Two different types of information on adverse events were abstracted: patient-reported symptoms and withdrawal of therapy due to a specified symptom. We categorized the tested beta-blockers by generation (early vs late) and lipid solubility (high vs low to moderate). DATA SYNTHESIS: The 15 trials involved more than 35,000 subjects. beta-Blocker therapy was not associated with a significant absolute annual increase in risk of reported depressive symptoms (6 per 1000 patients; 95% confidence interval [CI], -7 to 19). beta-Blockers were associated with a small significant annual increase in risk of reported fatigue (18 per 1000 patients; 95% CI, 5-30), equivalent to 1 additional report of fatigue for every 57 patients treated per year with beta-blockers. beta-Blockers were also associated with a small, significant annual increase in risk of reported sexual dysfunction (5 per 1000 patients; 95% CI, 2-8), equivalent to one additional report for every 199 patients treated per year. None of the risks of adverse effects differed significantly by degree of beta-blocker lipid solubility. The risk associated with reported fatigue was significantly higher for early-generation than for late-generation beta-blockers (P =.04). CONCLUSION: The conventional wisdom that beta-blocker therapy is associated with substantial risks of depressive symptoms, fatigue, and sexual dysfunction is not supported by data from clinical trials. There is no significant increased risk of depressive symptoms and only small increased risks of fatigue and sexual dysfunction. The risks of these adverse effects should be put in the context of the documented benefits of these medications.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
Packer, M., Bristow, M. R., Cohn, J. N., Colucci, W. S., Fowler, M. B., Gilbert, E. M., & Shusterman, N. H. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605233342101 · Cited by 4,649
Heart Disease: A Textbook of Cardiovascular Medicine.
(1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-101-3-415_3 · Cited by 4,109
The Handbook of Research Synthesis.
Howel, D., Cooper, H., & Hedges, L. V. (1995) · Biometrics · doi:10.2307/2533295 · Cited by 3,642
Arky, R. A. (1994) · Cited by 2,632
Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension)
Dahlöf, B., Hansson, L., Lindholm, L. H., Scherstén, B., Ekbom, T., & Wester, P.-O. (1991) · The Lancet · doi:10.1016/0140-6736(91)92589-t · Cited by 1,881
beta Blockade after myocardial infarction: systematic review and meta regression analysis
Freemantle, N., Cleland, J., Young, P., Mason, J., & Harrison, J. (1999) · BMJ · doi:10.1136/bmj.318.7200.1730 · Cited by 1,509
Hjalmarson, Å., Goldstein, S., Fagerberg, B., Wedel, H., Waagstein, F., Kjekshus, J., Wikstrand, J., El Allaf, D., Vítovec, J., Aldershvile, J., et al. (2000) · JAMA · doi:10.1001/jama.283.10.1295 · Cited by 1,399
Medical Research Council trial of treatment of hypertension in older adults: principal results.
Peart, S., Brennan, P. J., Broughton, P., Dollery, C. T., Hudson, M. F., Lever, A. F., Meade, T. W., Rose, G., & Pocock, S. (1992) · Cited by 1,360
β-Adrenergic Receptor Blockade in Chronic Heart Failure
Bristow, M. R. (2000) · Circulation · doi:10.1161/01.cir.101.5.558 · Cited by 1,028
A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure
(2001) · New England Journal of Medicine · doi:10.1056/nejm200105313442202 · Cited by 1,007
Neaton, J. D. (1993) · JAMA · doi:10.1001/jama.270.6.713 · Cited by 946
Petitti, D. B. (1994) · Medical Entomology and Zoology · Cited by 869
Randomised trial of treatment of hypertension in elderly patients in primary care.
Coope, J., & Warrender, T. S. (1986) · BMJ · doi:10.1136/bmj.293.6555.1145 · Cited by 725
Greenburg, G. A. (1981) · PubMed · Cited by 545
Krumholz, H. M., Radford, M. J., Wang, Y., Chen, J., Heiat, A., & Marciniak, T. A. (1998) · JAMA · doi:10.1001/jama.280.7.623 · Cited by 494
Grimm, R. H., Grandits, G. A., Prineas, R. J., McDonald, R. H., Lewis, C. E., Flack, J. M., Yunis, C., Svendsen, K., Liebson, P. R., Elmer, P. J., et al. (1997) · Hypertension · doi:10.1161/01.hyp.29.1.8 · Cited by 465
CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
Julian, D. G., Jackson, F. S., Prescott, R. J., & Szekely, P. (1982) · The Lancet · doi:10.1016/s0140-6736(82)92225-5 · Cited by 431
β-Adrenoceptor Antagonists: New Drugs and New Indications
Koch‐Weser, J., & Frishman, W. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108273050907 · Cited by 234
Increased antidepressant use in patients prescribed beta-blockers
Avorn, J. (1986) · JAMA · doi:10.1001/jama.255.3.357 · Cited by 218
Propranolol-induced depression.
Waal, H. J. (1967) · BMJ · doi:10.1136/bmj.2.5543.50 · Cited by 203
Hansteen, V, Moinichen, E., Lorentsen, E., Andersen, A., Strom, O., Soiland, K., Dyrbekk, D., Refsum, A. M., Tromsdal, A., Knudsen, K., et al. (1982) · BMJ · doi:10.1136/bmj.284.6310.155 · Cited by 201
Olsson, G., Rehnqvist, N., Sjögren, A., Erhardt, L., & Lundman, T. (1985) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(85)80360-0 · Cited by 201
Beta-blockers and central nervous system side effects
McAinsh, J., & Cruickshank, J. M. (1990) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(90)90092-g · Cited by 187
Increased prescribing of antidepressants subsequent to beta-blocker therapy
Thiessen, B. Q. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.150.11.2286 · Cited by 131
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
Taylor, S. H., Silke, B., Ebbutt, A., Sutton, G. C., Prout, B. J., & Burley, D. M. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211183072101 · Cited by 120
Beta-blockers and depression. Evidence against an association
Bright, R. A. (1992) · JAMA · doi:10.1001/jama.267.13.1783 · Cited by 103
Early or Deferred Zidovudine Therapy in HIV-Infected Patients without an AIDS-Defining Illness
Ioannidis, J. P. A., Cappelleri, J. C., Lau, J., Skolnik, P. R., Melville, B., Chalmers, T. C., & Sacks, H. S. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-122-11-199506010-00009 · Cited by 92
Pérez‐Stable, E. J., Halliday, R. A., Gardiner, P. S., Baron, R. B., Hauck, W. W., Acree, M. C., & Coates, T. J. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00304-1 · Cited by 86
The Impact of First‐Line Antihypertensive Drugs on Erectile Dysfunction
Barksdale, J. D., & Gardner, S. F. (1999) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.19.8.573.31526 · Cited by 55
Carney, R. M., Rich, M. W., tevelde, A., Saini, J., Clark, K. A., & Freedland, K. E. (1987) · The American Journal of Medicine · doi:10.1016/0002-9343(87)90689-9 · Cited by 54
Pérez‐Stable, E. J., Coates, T. J., Baron, R. B., Biró, B. S., Hauck, W. W., McHenry, K. S., Gardiner, P. S., & Feigal, D. W. (1995) · Journal of General Internal Medicine · doi:10.1007/bf02599912 · Cited by 23
Hall, P. E., Kendall, M. J., & SMITH, S. R. (1984) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1984.tb01089.x · Cited by 22
Practical aspects of using beta-adrenergic blockade in systolic heart failure
Gheorghiade, M., & Eichhorn, E. J. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00575-1 · Cited by 19
Cited by
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e3182776f83 · Cited by 2,410
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.07.013 · Cited by 1,555
Authors/Task Force Members (2006) · European Heart Journal · doi:10.1093/eurheartj/ehl001 · Cited by 1,336
Riegel, B., Moser, D. K., Anker, S. D., Appel, L. J., Dunbar, S. B., Grady, K. L., Gurvitz, M. Z., Havranek, E. P., Lee, C. S., Lindenfeld, J., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192628 · Cited by 961
Fihn, S. D., Gardin, J. M., Abrams, J., Berra, K., Blankenship, J. C., Dallas, A. P., Douglas, P. S., Foody, J. M., Gerber, T. C., Hinderliter, A. L., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318277d6a0 · Cited by 845
Metadata
- Authors
- Ko, D. T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2002-07-17
- Volume
- 288
- Issue
- 3
- Pages
- 351
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2016102355
- Cited by
- 556
- References
- 34
- FWCI
- 14.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.